abstract |
(57) [Summary] The present invention relates to a mutant MLP sequence wherein the mutation is made at the 10th base of exon 2 of the translated sequence or at position 3 of codon 112 of exon 4 of the translated sequence. Furthermore, the invention relates to a muscle-specific promoter and its use. |